Management of mycetoma

Author: Fahal, Ahmed Hassan

Source: Expert Review of Dermatology, Volume 5, Number 1, February 2010 , pp. 87-93(7)

Publisher: Expert Reviews

Buy & download fulltext article:

OR

Price: $73.00 plus tax (Refund Policy)

Abstract:

Mycetoma is a chronic specific granulomatous subcutaneous inflammatory disease. It is caused by true fungi or by bacteria, and hence it is usually classified as eumycetoma and actinomycetoma, respectively. It is a serious health problem in many tropical and subtropical areas, and has many medical, social and economical impacts. The treatment of mycetoma depends mainly on its etiological agent and the extent of the disease. Actinomycetoma is amenable to medical treatment by antibiotics and antimicrobial agents, while the medical treatment of eumycetoma by various antifungals is inadequate and disappointing. Combined medical and surgical treatment is the gold standard in eumycetoma. In general, the current treatment for mycetoma is unsatisfactory, it needs a long duration to affect cure, has many side effects, has a high relapse rate and is expensive for patients and health authorities. Controlled clinical trials for novel antibiotics and antifungals are needed for the management of mycetoma patients.

Keywords: actinomycetoma; eumycetoma; management; medical treatment; mycetoma; surgery

Document Type: Research article

DOI: http://dx.doi.org/10.1586/edm.09.67

Affiliations: 1: Professor of Surgery, Mycetoma Research Centre, University of Khartoum, PO Box 102, Khartoum, Sudan., Email: ahfahal@hotmail.com

Publication date: 2010-02-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page